Bharat Bio successfully completes Phase III trials of new oral...

Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol

نشر بتاريخ

Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.

Read Full Article

جارٍ التحميل...

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!

Business

Apple’s biggest contract manufacturer Foxconn readies 300-acre iPhone making campus in India with dorms for 30,000 employees

Foxconn is constructing a 300-acre campus in India, including dormitories for 30,000 workers....

بواسطة 0 7

International

Lights, video, confrontation - Trump's meeting with South African leader takes dramatic turn

Donald Trump hosted Cyril Ramaphosa in the Oval Office. Trump raised concerns about attacks on...

بواسطة 0 11

Sports

IPL playoffs history: MI pip RCB, inch closer to CSK's record

Mumbai Indians secured the final playoff spot in IPL 2025 after a dominant victory over Delhi...

بواسطة 0 11

Entertainment

Janhvi gets emotional , pays tribute to Sridevi

Janhvi Kapoor made an emotional red carpet debut at the 2025 Cannes Film Festival, reminiscing...

بواسطة 0 11

National

RPP Chairman Lingden to engage with youth under 40 ahead of planned movement

KATHMANDU: Rajendra Lingden, Chairman of the Rastriya Prajatantra Party (RPP) and leader of the...

بواسطة 0 22